SYMBICORT
Showing 1 - 25 of 193
Airway Inflammation, Asthma Trial in United Kingdom (SYMBICORT and salbutamol)
Active, not recruiting
- Airway Inflammation
- Asthma
- SYMBICORT and salbutamol
-
Bradford, United Kingdom
- +5 more
Aug 22, 2022
Exercise Performance Trial in Copenhagen (Symbicort, Formoterol, Placebo)
Not yet recruiting
- Exercise Performance
- Symbicort
- +3 more
-
Copenhagen, DenmarkAugust Krogh Building
Oct 23, 2023
Asthma, Asthma Chronic, Asthma Bronchial Trial in Edegem (Z7200, Symbicort® Turbohaler®)
Completed
- Asthma
- +3 more
- Z7200
- Symbicort® Turbohaler®
-
Edegem, Antwerp, BelgiumAntwerp University Hospital
Nov 16, 2021
Asthma Trial in Ruddington (Z7200 without oral activated charcoal, Symbicort Turbohaler without oral activated charcoal, Z7200
Completed
- Asthma
- Z7200 without oral activated charcoal
- +3 more
-
Ruddington, United KingdomQuotient Clinical Ltd
Feb 9, 2022
Asthma Trial in Ruddington (Z7200 without oral activated charcoal, Symbicort Turbohaler without oral activated charcoal, Z7200
Completed
- Asthma
- Z7200 without oral activated charcoal
- +3 more
-
Ruddington, United KingdomQuotient Clinical Ltd
Feb 9, 2022
Asthma Trial in Medford (Budesonide 80 µg and Formoterol Fumarate Dihydrate 4.5 µg, Symbicort, 80 Mcg-4.5 Mcg/Inh Inhalation
Recruiting
- Asthma
- Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5 μg
- +2 more
-
Medford, OregonVelocity Clinical Research
May 6, 2022
Respiratory Tract Infections, Bronchiolitis Obliterans, Cryptogenic Organizing Pneumonia Trial in Montreal (Prednisone,
Terminated
- Respiratory Tract Infections
- +3 more
- Prednisone
- +3 more
-
Montreal, Quebec, CanadaMaisonneuve-Rosemont Hospital (Hôpital Maisonneuve-Rosemont)
Oct 13, 2021
COPD (COPD) Trial in Germany (BFF, Symbicort Turbuhaler)
Completed
- Chronic Obstructive Pulmonary Disease (COPD)
- BFF
- Symbicort Turbuhaler
-
Frankfurt/Main, Germany
- +3 more
Feb 21, 2022
Pulmonary Disease, Chronic Obstructive Trial in United States (Budesonide, budesonide/formoterol, Ipratropium/albuterol)
Completed
- Pulmonary Disease, Chronic Obstructive
- Budesonide
- +2 more
-
Birmingham, Alabama
- +6 more
Jan 15, 2021
Chronic Obstructive Lung Disease Trial in London (Symbicort® total dose 400ug/12ug, Symbicort® total dose 800ug/24ug, Formoterol
Completed
- Chronic Obstructive Lung Disease
- Symbicort® total dose 400ug/12ug
- +3 more
-
London, United KingdomRoyal Brompton and Harefield NHS trust
Oct 30, 2020
Covid-19 Infection, Hospitalization in Respiratory Disease Department Trial in Paris (2: Usual practice + SYMBICORT RAPIHALER,
Terminated
- Covid-19 Infection
- Hospitalization in Respiratory Disease Department
- 2: Usual practice + SYMBICORT RAPIHALER
- 1: Usual practice
-
Paris, FranceHôpital Bichat - Service de Pneumologie
Jul 31, 2021
Exercise Induced Asthma Trial in Boston (Budesonide/Formoterol, Budesonide)
Terminated
- Exercise Induced Asthma
-
Boston, Massachusetts
- +1 more
Jul 2, 2021
Asthma, Severe Eosinophilic Asthma Trial in Worldwide (Symbicort®, Fasenra®, Ventolin®)
Active, not recruiting
- Asthma
- Severe Eosinophilic Asthma
- Symbicort®
- +2 more
-
Brest Cedex, France
- +22 more
Aug 24, 2022
Asthma Trial in United Kingdom (Budesonide and formoterol fumarate dehydrate (BF) SPIROMAX, SYMBICORT TURBOHALER budesonide and
Completed
- Asthma
- Budesonide and formoterol fumarate dehydrate (BF) SPIROMAX
- SYMBICORT TURBOHALER budesonide and formoterol fumarate
-
Axbridge, United Kingdom
- +73 more
Nov 5, 2021
Asthma Trial in Denver (fluticasone propionate and salmeterol, budesonide and formoterol)
Completed
- Asthma
- fluticasone propionate and salmeterol
- budesonide and formoterol
-
Denver, ColoradoNational Jewish Health
Jan 15, 2021
Asthma Trial in El Paso (pMDI budesonide/formotrol 160/4.5 is in group 1, Symbicort 160/4.5 plus Aerochamber Plus included in
Completed
- Asthma
- pMDI budesonide/formotrol 160/4.5 is in group 1
- Symbicort 160/4.5 plus Aerochamber Plus included in group 2
-
El Paso, TexasWestern Sky Medical Research
Aug 12, 2020
(s)of Airflow Limitation in Moderate-severe Persistent Asthma
Recruiting
- Asthma
- budesonide/formoterol
- +3 more
-
Lakewood, CaliforniaArthur F Gelb Medical Corporation
Feb 5, 2021
Asthma Trial in United States (Budesonide/Formoterol fumarate dihydrate, Symbicort, Placebo)
Completed
- Asthma
- Budesonide/Formoterol fumarate dihydrate
- +2 more
-
Birmingham, Alabama
- +94 more
Aug 1, 2022
Asthma Trial in Palermo (Symbicort Turbohaler plus Turbo+, Symbicort Turbohaler without Turbo+)
Completed
- Asthma
- Symbicort Turbohaler plus Turbo+
- Symbicort Turbohaler without Turbo+
-
Palermo, Sicily, ItalyInstitute of Biomedicine and Molecular Immunology (IBIM), Nation
Jun 5, 2020
Asthma, COPD Trial in New Taipei City (Budesonide, Formoterol)
Completed
- Asthma
- COPD
-
New Taipei City, TaiwanClinical Pharmacology Unit of Mackay Memorial Hospital Tamshui B
Jul 28, 2020
COPD Trial in China (CHF 1535 100/6 µg pMDI plus Symbicort® Turbohaler® Placebo, Symbicort® Turbohaler® plus CHF 1535 pMDI
Recruiting
- Chronic Obstructive Pulmonary Disease
- CHF 1535 100/6 µg pMDI plus Symbicort® Turbohaler® Placebo
- Symbicort® Turbohaler® plus CHF 1535 pMDI Placebo
-
Hefei, Anhui, China
- +52 more
Jun 15, 2021
COPD Trial in Vancouver (Fluticasone group, Budesonide group, Formoterol group)
Unknown status
- Chronic Obstructive Pulmonary Disease
- Fluticasone group
- +2 more
-
Vancouver, British Columbia, Canada
- +1 more
Mar 26, 2020
Asthma Trial in Lakewood (fluticasone/salmeterol in all asthmatics, budesonide/formoterol or fluticasone/salmeterol in all
Recruiting
- Asthma
- fluticasone/salmeterol in all asthmatics
- budesonide/formoterol or fluticasone/salmeterol in all asthmatics
-
Lakewood, CaliforniaArthur F Gelb Medical Corporation
Jul 26, 2020